IBM Shares Face a Crucial Earnings Test
27.01.2026 - 06:07:04Investors are positioning themselves ahead of a pivotal moment for the technology conglomerate. IBM is scheduled to release its fourth-quarter financials after the market closes on January 28, 2026, placing its recent performance and future guidance under intense scrutiny. Following a period of modest consolidation in recent weeks, the market's focus has sharpened on whether the company can meet ambitious growth targets set for the coming year.
The consensus on Wall Street leaves little room for disappointment. Analysts project revenue for the quarter ended December 31, 2025, to land between $19.21 billion and $19.23 billion. This would represent a solid year-over-year increase of approximately 9.5%.
Profitability metrics are also under the microscope. Adjusted earnings per share (EPS) are forecast to be in the range of $4.29 to $4.33. Having surpassed estimates in the third quarter, IBM’s management team is under pressure to confirm that positive trend.
Evercore ISI Highlights a Potential Entry Point
Despite the high bar, some analysts remain bullish. Investment firm Evercore ISI recently reiterated its confidence. Analyst Amit Daryanani confirmed an "Outperform" rating and raised the price target from $315 to $330. The firm even added IBM to its "Tactical Outperform List."
Evercore cites a robust mainframe infrastructure cycle and ongoing improvements in the consulting segment as key drivers for optimism. The focus rests on restructuring efforts and cost-saving initiatives expected to support profit margins. The firm anticipates that IBM’s results will meet, or potentially slightly exceed, current consensus estimates.
Should investors sell immediately? Or is it worth buying IBM?
Forward Guidance and Strategic Moves Take Center Stage
For many shareholders, the outlook for the full 2026 fiscal year may hold more significance than the quarterly results. Current projections suggest revenue growth in the mid-single-digit percentage range. Furthermore, the company is expected to generate free cash flow of around $15 billion.
Two critical areas will heavily influence the investment thesis moving forward. First, the planned mid-2026 closure of the Confluent acquisition is seen as crucial, with investors seeking clarity on its expected contribution to software growth. Second, the performance of the Red Hat division is being watched closely, as growth there is anticipated to have moderated somewhat in Q4.
Key Data at a Glance:
- Earnings Date: January 28, 2026 (after market close)
- Revenue Forecast: ~$19.21 billion (+9.5% YoY)
- Earnings Per Share: ~$4.29 – $4.33
- Average Price Target: ~$305
- 2026 Free Cash Flow Target: ~$15 billion
IBM’s stock currently trades in the $295 to $296 range, sitting below its 52-week high near $325. From a technical perspective, a sustained breakout above the $300 level would be necessary to re-establish a clear upward trend. Activity in the options market is already pricing in elevated volatility for the latter part of the week, signaling an expectation for significant price movement following the earnings release.
Ad
IBM Stock: Buy or Sell?! New IBM Analysis from January 27 delivers the answer:
The latest IBM figures speak for themselves: Urgent action needed for IBM investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 27.
IBM: Buy or sell? Read more here...


